DOCK2: A novel FLT3/ITD leukemia drug target.

DOCK2: A novel FLT3/ITD leukemia drug target.
Oncotarget. 2017 Oct 24;8(51):88253-88254
Authors: Wu M, Small D, Duffield AS
PMID: 29179430 [PubMed]

Source: Oncotarget - November 29, 2017 Category: Cancer & Oncology Tags: Oncotarget Source Type: research